American Cancer Society Joins the Worldwide Innovative Network (WIN) in Personalized Cancer Medicine Consortium - WIN Consortium
Posted: Thursday, September 19, 2024
News
Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings
Posted: Thursday, May 23, 2024
Abu Dhabi’s WIN Symposium gathers oncology leaders
Posted: Friday, March 15, 2024
WIN Consortium chair aims to promote collaboration, innovation in personalized cancer medicine
Posted: Tuesday, January 23, 2024
“New Leadership, vision for the Worldwide Innovative Network Consortium in Precision Oncology” View The Cancer Letter 49-45.
Posted: Thursday, December 14, 2023
Prof. Wafik El-Deiry elected Chair of the Worldwide Innovative Network (WIN) in Personalized Cancer Medicine Association - WIN Consortium
Posted: Thursday, December 07, 2023
Burjeel Medical City selected to join the Worldwide Innovative Networking in Personalized Cancer Medicine - WIN Consortium
Posted: Wednesday, May 31, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
Posted: Friday, March 31, 2023
Exploring Precision Oncology - Interview with Dr. Razelle Kurzrock, Chief Medical Officer and Dr. Sewanti Limaye at WIN 2022 Symposium
Posted: Friday, November 18, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
Posted: Monday, November 07, 2022
Transcriptomics Plus ‘Immune Tolerance’ of Normal Tissue Shows Promise in Lung Cancer Prognosis
Posted: Tuesday, September 27, 2022